• AI Health Checks
  • George Tomeski in the Telegraph: The welfare system is working, but not for patients or taxpayers

    May 7, 2026

    0 comments

    Helfie founder and CEO George Tomeski has been featured in The Telegraph (UK), tackling some of the most uncomfortable truths about Britain’s health crisis and making the case for prevention and early detection as the pivotal path forward. 

    Sticking Plaster on a Haemorrhage

    Britain’s welfare bill for working-age sickness and disability has hit £56bn a year, with forecasts pushing it to £70bn by 2029. The government’s response? Cut Universal Credit health payments for new claimants from £97 to £50 a week. It’s a sticking plaster on a haemorrhage, and it ignores the real question entirely.

    Why, in an age of remarkable medical progress, are so many of us so unhealthy? And who actually benefits from that?

    The Real Cost of Inaction

    The numbers are staggering. Nearly 2.8 million people, 7% of Britain’s workforce, are out of work due to long-term sickness, costing the economy £132bn in lost output every year. Yet every political lever being pulled treats the symptom, not the cause.

    A System Working Exactly as Designed

    Here’s the uncomfortable truth: the current system isn’t broken. It’s working exactly as designed, just not for patients or taxpayers.

    Think about it. Someone diagnosed with Type 2 diabetes becomes a lifelong customer: of medications, appointments, and repeat prescriptions. The same pattern repeats across chronic disease. For the pharmaceutical industry, preventable illness is a revenue stream. A medicated, anxious workforce is decades of guaranteed demand. A filled hospital bed is income.

    Prevention, by contrast, generates no bills. It produces wellbeing, something the system has never learned to price. The market rewards reaction, not resilience.

    The Early Warning Signals We’re Ignoring

    But here’s what should change the entire conversation: most of the conditions keeping people out of work, musculoskeletal disorders, cardiovascular disease, mental health disorders, respiratory illness, are detectable and manageable long before they become disabling. Our bodies give off early warning signals, and today’s technology can read them.

    Smartphones can already monitor health signals that flag risk well before a GP visit or a fit note. Low-cost, AI-driven preventative health tools can identify problems early, prompt intervention sooner, and dramatically cut the downstream burden on individuals, employers, the NHS, and the Treasury.

    This isn’t just good for patients. It’s transformative for employers battling absence, insurers carrying avoidable risk, and a Chancellor desperate for growth.

    What’s missing is political will. One concrete step: make certified preventative health monitoring tax-free through employers. Businesses get a reason to invest, workers stay healthier longer, and economic inactivity falls.

    The technology exists. The need is urgent. The £132bn annual cost of doing nothing is one Britain simply cannot keep deferring.

    Helfie founder and CEO George Tomeski has been featured in The Telegraph (UK), tackling some of the most uncomfortable truths about Britain’s health crisis and making the case for prevention and early detection as the pivotal path forward. 

    Sticking Plaster on a Haemorrhage

    Britain’s welfare bill for working-age sickness and disability has hit £56bn a year, with forecasts pushing it to £70bn by 2029. The government’s response? Cut Universal Credit health payments for new claimants from £97 to £50 a week. It’s a sticking plaster on a haemorrhage, and it ignores the real question entirely.

    Why, in an age of remarkable medical progress, are so many of us so unhealthy? And who actually benefits from that?

    The Real Cost of Inaction

    The numbers are staggering. Nearly 2.8 million people, 7% of Britain’s workforce, are out of work due to long-term sickness, costing the economy £132bn in lost output every year. Yet every political lever being pulled treats the symptom, not the cause.

    A System Working Exactly as Designed

    Here’s the uncomfortable truth: the current system isn’t broken. It’s working exactly as designed, just not for patients or taxpayers.

    Think about it. Someone diagnosed with Type 2 diabetes becomes a lifelong customer: of medications, appointments, and repeat prescriptions. The same pattern repeats across chronic disease. For the pharmaceutical industry, preventable illness is a revenue stream. A medicated, anxious workforce is decades of guaranteed demand. A filled hospital bed is income.

    Prevention, by contrast, generates no bills. It produces wellbeing, something the system has never learned to price. The market rewards reaction, not resilience.

    The Early Warning Signals We’re Ignoring

    But here’s what should change the entire conversation: most of the conditions keeping people out of work, musculoskeletal disorders, cardiovascular disease, mental health disorders, respiratory illness, are detectable and manageable long before they become disabling. Our bodies give off early warning signals, and today’s technology can read them.

    Smartphones can already monitor health signals that flag risk well before a GP visit or a fit note. Low-cost, AI-driven preventative health tools can identify problems early, prompt intervention sooner, and dramatically cut the downstream burden on individuals, employers, the NHS, and the Treasury.

    This isn’t just good for patients. It’s transformative for employers battling absence, insurers carrying avoidable risk, and a Chancellor desperate for growth.

    What’s missing is political will. One concrete step: make certified preventative health monitoring tax-free through employers. Businesses get a reason to invest, workers stay healthier longer, and economic inactivity falls.

    The technology exists. The need is urgent. The £132bn annual cost of doing nothing is one Britain simply cannot keep deferring.

    0 comments

    Related News & Media

    Health Innovation South West and Helfie AI announce partnership to evaluate digital-first hypertension screening.

    October 19, 2026

    Read more

    Helfie Named in TIME’s World’s Top HealthTech Companies of 2026

    October 13, 2026

    Read more

    Rania Awad (Chief Strategy Officer, Helfie AI) and Hon. Grace Mercy Osewe (Homa Bay County).

    Helfie Signs MOU with Homa Bay Kenya Ministry of Health for TB and Hypertension Screening Pilot

    October 9, 2026

    Read more

    From the Frontline of Preventive Health to a Signed MOU: My Week in Kenya

    October 8, 2026

    Read more

    Surgery without anaesthesia, mammograms, AI. The evolution of breast cancer screening.

    October 8, 2026

    Read more

    The Silent Symptoms of Heart Disease: Why Prevention Starts in Our Communities

    September 29, 2026

    Read more

    Helfie appoints veteran CFO John Rego to lead financial strategy.

    September 2, 2026

    Read more

    Helfie Shortlisted for Prix Galien USA 2026 “Best Digital Health Solution” Award.

    August 13, 2026

    Read more

    Patrick Gates and Sunita Parasuraman, Non-Executive Directors, Helfie

    Helfie strengthens its board with heavyweight tech and governance appointments.

    August 11, 2026

    Read more

    Helfie partners with Microsoft to power faster, more secure health screening.

    July 22, 2026

    Read more

    See All Articles